Medicine Description kidrolase 10000i
Kidrolase 10,000 IU Injection is a medication that employs the enzyme L-asparaginase to treat specific types of hematological malignancies. It works by catalyzing the hydrolysis of asparagine, an amino acid that is crucial for the survival and proliferation of certain cancerous cells, particularly in leukemia and lymphoma. By depleting the levels of asparagine in the bloodstream, Kidrolase effectively starves these malignant cells, leading to their death and limiting tumor growth. This mechanism is particularly beneficial in patients whose tumors are unable to synthesize sufficient asparagine, making them dependent on external sources for survival.
Indications and Uses of Kidrolase 10,000 IU Injection
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Certain types of Lymphoma including Lymphoblastic Lymphoma
- As part of multi-agent chemotherapy regimens for hematological cancers
Side Effects of Kidrolase 10,000 IU Injection
- Hypersensitivity reactions
- Nausea and vomiting
- Pancreatitis
- Hepatotoxicity
- Thrombosis
- Hemorrhage
- Neurotoxicity
- Fatigue
Storage and Handling
Kidrolase 10,000 IU Injection should be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). Protect from light and do not freeze. It should be kept out of reach of children and disposed of properly if expired or no longer needed.
Patient Advice and Precautions
Patients should adhere strictly to their treatment schedules and maintain regular follow-up appointments with their healthcare provider. It is crucial to monitor for signs of allergic reactions and report any unusual symptoms immediately. Ensure hydration and discuss any potential interactions with other medications or supplements with the healthcare team. Pregnant or breastfeeding individuals should inform their doctor prior to use.